Tourmaline Bio Inc (NASDAQ:TRML) shares, rose in value, with the stock price down by -2.00% to the previous day’s close as strong demand from buyers drove the stock to $15.68.
Actively observing the price movement in the last trading, the stock closed the session at $16.00. Referring to stock’s 52-week performance, its high was $48.31, and the low was $9.18. On the whole, TRML has fluctuated by -31.53% over the past month.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TRML’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TRML currently trading nearly -19.07% and -48.32% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 26.67, while the 7-day volatility ratio is showing 6.72% which for the 30-day chart, stands at 7.59%. Furthermore, Tourmaline Bio Inc (TRML)’s beta value is 2.44, and its average true range (ATR) is 1.87.
A comparison of Tourmaline Bio Inc (TRML) with its peers suggests the former has fared considerably weaker in the market. TRML showed an intraday change of -2.00% in last session, and over the past year, it shrunk by -38.02%%.
Data on historical trading for Tourmaline Bio Inc (NASDAQ:TRML) indicates that the trading volumes over the past 3 months, they’ve averaged 430.53K. According to company’s latest data on outstanding shares, there are 20.34 million shares outstanding.
Nearly 39.73% of Tourmaline Bio Inc’s shares belong to company insiders and institutional investors own 36.47% of the company’s shares. The stock has fallen by -40.11% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TRML stock heading into the next quarter.
